Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q).

被引：0
|
作者：
Pellagatti, A
Giagounidis, A
Killick, S
Campbell, LJ
Wraight, V
Langford, CF
Fidler, C
Oscier, D
Aul, C
Wainscoat, JS
Boultwood, J
机构：
[1] John Radcliffe Hosp, LRF Mol Haematol Unit, Oxford OX3 9DU, England
[2] St Johannes Hosp, Med Klin 2, Duisburg, Germany
[3] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England
[4] Sanger Inst, Microarray Facil, Cambridge, England
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2363.2363
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2363
引用
收藏
页码：649A / 649A
页数：1
相关论文
共 50 条
  • [31] Morphological alterations of megakaryocytes in myelodysplastic syndromes with del(5q), del(20q), -7 and del(7q)
    Avino, Daniela
    Di Palma, Anna
    Caliendo, Irene
    Soriente, Ilaria
    Di Feo, Angelo
    Danise, Paolo
    BIOCHIMICA CLINICA, 2016, 40 (03) : 229 - 233
  • [32] DEFINING LIKELIHOOD OF FUTURE RESPONSE IN PATIENTS WITH DEL(5Q) MYELODYSPLASTIC SYNDROMES (MDS) TREATED WITH LENALIDOMIDE
    Gerds, A. T.
    List, A. F.
    Giagounidis, A.
    Hellstrom-Lindberg, E.
    Li, J. Shiansong
    Swern, A. S.
    Sugrue, M. M.
    Fenaux, P.
    Sekeres, M. A.
    LEUKEMIA RESEARCH, 2015, 39 : S109 - S109
  • [33] Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q).
    Zemanova, Zuzana
    Michalova, Kyra
    Brezinova, Jana
    Lizcova, Libuse
    Izakova, Silvia
    Bystricka, Dagmar
    Sarova, Iveta
    Berkova, Adela
    Siskova, Magda
    Neuwirtova, Radana
    Cerna, Olga
    Cermak, Jaroslav
    BLOOD, 2009, 114 (22) : 649 - 649
  • [34] Relative distribution of different compartments of CD34+cells in the bone marrow of patients with myelodysplastic syndromes
    Matarraz, S.
    Lopez, A.
    Salvador, C.
    Fernandez-Mosteirin, N.
    Giralt, M.
    Orfao, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 233 - 233
  • [35] Myelodysplastic syndromes 5q deletion in childhood
    Iriani, A.
    LEUKEMIA RESEARCH, 2013, 37 : S93 - S93
  • [36] Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring
    Jaedersten, Martin
    Karsan, Aly
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 177 - 180
  • [37] Variability in the extent of del(5q) and its clinical implication in myelodysplastic syndromes (MDS).
    Zemanova, Zuzana
    Brezinova, Jana
    Svobodova, Karla
    Lhotska, Halka
    Izakova, Silvia
    Sarova, Iveta
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Variability in the size of del(5q) and its clinical implication in myelodysplastic syndromes (MDS)
    Zemanova, Zuzana
    Sejgunovova, Nikola
    Svobodova, Karla
    Lhotska, Halka
    Vidlakova, Denisa
    Aghova, Tatiana
    Lizcova, Libuse
    Izakova, Silvia
    Mendlikova, Iveta
    Ransdorfova, Sarka
    Hodanova, Lucie
    Pavlistova, Lenka
    Belickova, Monika
    Brezinova, Jana
    Cermak, Jaroslav
    Stopka, Tomas
    Jonasova, Anna
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 559 - 560
  • [39] Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial
    Almeida, Antonio
    Fenaux, Pierre
    Garcia-Manero, Guillermo
    Goldberg, Stuart L.
    Groepper, Stefanie
    Jonasova, Anna
    Vey, Norbert
    Castaneda, Carmen
    Zhong, Jianhua
    Beach, C. L.
    Santini, Valeria
    LEUKEMIA & LYMPHOMA, 2018, 59 (09) : 2135 - 2143
  • [40] SURVIVAL OF PATIENTS WITH DE NOVO MYELODYSPLASTIC SYNDROME AND del(5q)
    Gritsaev, S. V.
    Martynkevich, I. S.
    Petrova, E. V.
    Martynenko, L. S.
    Kostroma, I. I.
    Ivanova, M. P.
    Tsybakova, N. Yu.
    Kozlovskaya, M. A.
    Sergeyev, A. N.
    Tiranova, S. A.
    Potikhonova, N. A.
    Abdulkadyrov, K. M.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (01): : 3 - 9
12345